Press Releases

Date Title and Summary
Toggle Summary New Data Presented at ESTRO 36 Reinforce Unmatched Versatility and Precision of the CyberKnife® System
Studies Show the System Provides Excellent Outcomes Throughout the Cancer Treatment Journey, from Primary Cases to Recurrence and Metastatic Disease SUNNYVALE, Calif. , May 11, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that studies on the clinical use of the
Toggle Summary Accuray to Showcase CyberKnife® and Radixact™ Systems at ESTRO 2017
Innovations in Hardware and Software Solutions Reinforce the Benefits of Accuray Systems in Treating a Wide Range of Cancer Cases SUNNYVALE, Calif. , May 3, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company will highlight its portfolio of radiation therapy
Toggle Summary CyberKnife® System Provides Effective Treatment Option with Minimal Side Effects and Excellent Cosmesis for Early Stage Breast Cancer Patients
Robotic Radiosurgery System's Unique Motion Management Technique Limits Toxicity and Preserves Cosmesis in Convenient, 5-Fraction Treatment Regimen SUNNYVALE, Calif. , May 2, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today preliminary results from a prospective, phase I
Toggle Summary Accuray Names Lionel Hadjadjeba Chief Commercial Officer
Chief Operating Officer Position Eliminated SUNNYVALE, Calif. , April 27, 2017 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) today reported the appointment of Lionel Hadjadjeba as senior vice president, chief commercial officer effective immediately.
Toggle Summary Accuray Third Quarter Gross Orders Increase 49% YoY; Backlog Up 21%
SUNNYVALE, Calif. , April 27, 2017 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third fiscal quarter and nine months ended March 31, 2017 . Fiscal Third Quarter Highlights Ending backlog increased 21 percent year-over-year to $450.0 million ; gross
Toggle Summary Accuray To Report Fiscal 2017 Third Quarter Financial Results On April 27, 2017
SUNNYVALE, Calif. , April 13, 2017 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) will report results for its fiscal third quarter ended March 31, 2017 on Thursday, April 27, 2017 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT / 4:30 p.m.
Toggle Summary Accuray 2017 Regional AERO Summit Brings Together Leading Oncology Specialists to Advance Cancer Patient Care
SUNNYVALE, Calif. , April 12, 2017 /PRNewswire/ -- Renowned radiation oncologists, physicists, therapists and administrators from around the world joined together at the Accuray Exchange in Radiation Oncology (AERO™) Users' Summit to discuss best practices and further collaborations that will
Toggle Summary First Cancer Patients in Africa Treated with the TomoTherapy® System
Premier Algerian Cancer Center Now Provides Cancer Patients with Leading-Edge Radiation Treatments SUNNYVALE, Calif. , April 11, 2017 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today that the newly built Radiotherapy and Medical Oncology Center of Sidi Abdellah , Algeria is now
Toggle Summary Accuray Launches New Cancer Patient Websites
SUNNYVALE, Calif. , March 2, 2017 /PRNewswire/ -- The Internet is one of the first places patients turn to for healthcare information after receiving a cancer diagnosis, according to the American Cancer Society . Accuray Incorporated (NASDAQ: ARAY) is launching www.cyberknife.com and
Toggle Summary Accuray to Present at Cowen and Company 37th Annual Healthcare Conference on March 6, 2017
SUNNYVALE, Calif. , Feb. 21, 2017 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY), announced today that the Company will present at Cowen and Company's 37 th Annual Healthcare Conference in Boston on Monday, March 6, 2017 . Accuray's fireside chat with analyst Joshua Jennings , M.D.

*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.